Zevra Therapeutics: Of Form 8k And The Pro Forma Financial Information Required By Item 9.01(b) Of Form 8k, Which Were Not Included In The Original Form 8k Pursuant To Items 9.01(a)(3) And (b)(2) Of Form 8k. Except As Provided Herein, The Disclosures Made In The Original Form 8k Remain Unchanged

Show full article

This functionality is available for registred users only

• Full name
  Zevra Therapeutics Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***